Filing Details
- Accession Number:
- 0001104659-25-015319
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-19 21:45:16
- Reporting Period:
- 2025-02-14
- Filing Date:
- 2025-02-19
- Accepted Time:
- 2025-02-19 21:45:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649904 | Rhythm Pharmaceuticals Inc. | RYTM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260835 | Paul Christopher German | 222 Berkeley Street, 12Th Floor Boston MA 02116 | Corporate Controller & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-16 | 1,807 | $0.00 | 2,705 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-19 | 635 | $57.22 | 2,070 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2025-02-14 | 7,225 | $0.00 | 7,225 | $0.00 |
| Common Stock | Stock Options (Right to Buy) | Acquisiton | 2025-02-14 | 5,400 | $0.00 | 5,400 | $56.69 |
| Common Stock | Restricted Stock Units | Disposition | 2025-02-16 | 1,807 | $0.00 | 1,807 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,225 | No | 4 | A | Direct | ||
| 5,400 | 2035-02-13 | No | 4 | A | Direct | |
| 5,418 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- Includes 103 additional shares acquired under the Issuer's Employee Stock Purchase Plan.
- The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.
- The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
- The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.
Billionaire Hedge Funds
